Mechanistic studies have further shown that MIF facilitates osteosarcoma cell proliferation and metastasis by activating the RAS/MAPK signaling axis, with the degree of pathway activation closely tied to tumor burden and patient prognosis (56). This evidence concerns the gene MIF and neoplasm.